Mario Cazzola

Citado por

	Total	Desde 2019
Citas	95850	49578
Índice h	136	91
Índice i10	488	301

10000

5000

2500

7500

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024304 262 370 405 529 446 636 831 1086 1121 1515 1584 1839 2148 2403 3087 3532 4540 4791 5721 5837 5861 7632 9669 8986 9533 7762

Acceso público

Ver todo

133 artículos

12 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Malcovati LucaUniversity of PaviaDirección de correo verificada de unipv.it
Passamonti FrancescoUniversity of Insubria, Varese, ItalyDirección de correo verificada de uninsubria.it
Della Porta Matteo GiovanniProfessor of Hematology, Humanitas University, Milan - ItalyDirección de correo verificada de hunimed.eu
Invernizzi RosangelaUniversity of PaviaDirección de correo verificada de unipv.it
Robert KralovicsPrincipal Investigator, Medical University of ViennaDirección de correo verificada de meduniwien.ac.at
Luca ArcainiDepartment of Molecular Medicine, University of PaviaDirección de correo verificada de unipv.it
Tiziano BarbuiFondazione per la Ricerca Ospedale Maggiore di BergamoDirección de correo verificada de asst-pg23.it
Alessandro RambaldiProfessore di Ematologia, Università degli Studi di MilanoDirección de correo verificada de unimi.it
Vannucchi AMProfessor of Hematology, University of FlorenceDirección de correo verificada de unifi.it
Paolo Arosioprofessore di Biologia Molecolare, Università di BresciaDirección de correo verificada de unibs.it
Marzia VarettoniDirigente Medico, Dipartimento di Ematologia e Oncologia, Fondazione IRCCS Policlinico San MatteoDirección de correo verificada de smatteo.pv.it
Jelena Milosevic FeenstraThermo Fisher ScientificDirección de correo verificada de thermofisher.com
Ashot S. HarutyunyanDepartment of Human Genetics, McGill UniversityDirección de correo verificada de mail.mcgill.ca
Elli PapaemmanuilMemorial Sloan Kettering Computational Oncology ServiceDirección de correo verificada de mskcc.org
Locatelli FrancoUniversity of Pavia, Ospedale Bambino Gesù, Roma, Policlinico San MatteoDirección de correo verificada de opbg.net
Seishi OgawaDirección de correo verificada de umin.ac.jp
Rossella ManfrediniUniversità di Modena e Reggio EmiliaDirección de correo verificada de unimore.it
Christopher JacksonStatistician - MRC Biostatistics Unit, Cambridge, UKDirección de correo verificada de mrc-bsu.cam.ac.uk
Donna NeubergDana-Farber Cancer InstituteDirección de correo verificada de jimmy.harvard.edu

Seguir

Mario Cazzola

Professor of Hematology, University of Pavia

Dirección de correo verificada de unipv.it

Hematology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ... Blood, The Journal of the American Society of Hematology 127 (20), 2391-2405, 2016	11456	2016
A gain-of-function mutation of JAK2 in myeloproliferative disorders R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ... New England Journal of Medicine 352 (17), 1779-1790, 2005	4751	2005
Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012	3516	2012
The repertoire of mutational signatures in human cancer LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ... Nature 578 (7793), 94-101, 2020	2784	2020
Somatic mutations of calreticulin in myeloproliferative neoplasms KR Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi New England Journal of Medicine 369 (25), 2379-2390, 2013	2443	2013
Clinical and biological implications of driver mutations in myelodysplastic syndromes E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ... Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013	2087	2013
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020	1743	2020
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013	1670	2013
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022	1613	2022
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ... New England Journal of Medicine 365 (15), 1384-1395, 2011	1472	2011
Efficacy and safety of low-dose aspirin in polycythemia vera R Landolfi, R Marchioli, J Kutti, H Gisslinger, G Tognoni, C Patrono, ... New England Journal of Medicine 350 (2), 114-124, 2004	1330	2004
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ... Journal of clinical oncology 25 (23), 3503-3510, 2007	1319	2007
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ... Journal of Clinical Oncology 23 (30), 7594-7603, 2005	1151	2005
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and … F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ... Blood, The Journal of the American Society of Hematology 115 (9), 1703-1708, 2010	1124	2010
The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020	974	2020
Mutations and prognosis in primary myelofibrosis AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ... Leukemia 27 (9), 1861-1869, 2013	899	2013
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ... Leukemia 27 (9), 1874-1881, 2013	850	2013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ... Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013	828	2013
Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020	784	2020
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ... Blood, The Journal of the American Society of Hematology 123 (10), 1544-1551, 2014	773	2014

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores